ArticleBiologics : targets & therapy2023

The Effect of Two Years of Secukinumab Treatment on Bone Metabolism in Patients with Radiographic Axial Spondyloarthritis: Results from Daily Clinical Practice.

Mark Siderius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.